Zkusit zdarma
Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc.

PTGX
Cena:
 
 
Valuace
100
Růst
70
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress

Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress

7:05 01-06-2026

NEWARK, CA / ACCESS Newswire / June 1, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "...

Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026

Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026

7:05 28-05-2026

NEWARK, CA / ACCESS Newswire / May 28, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" ...

Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update

Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update

16:05 05-05-2026

ICOTYDE™ (icotrokinra) approved by FDA in March for moderate-to-severe plaque psoriasis, triggerin...

Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration

Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration

9:05 28-04-2026

Opt-out election makes Protagonist eligible for $200 million upon exercise and an additional $200 mi...

Protagonist Therapeutics Reports Granting of Inducement Awards

Protagonist Therapeutics Reports Granting of Inducement Awards

16:05 16-04-2026

NEWARK, CA / ACCESS Newswire / April 16, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today r...

SG Americas Securities LLC Sells 21,249 Shares of Protagonist Therapeutics, Inc. $PTGX

SG Americas Securities LLC Sells 21,249 Shares of Protagonist Therapeutics, Inc. $PTGX

5:03 06-04-2026

SG Americas Securities LLC reduced its holdings in Protagonist Therapeutics, Inc. (NASDAQ: PTGX) by ...

Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting

Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting

10:05 28-03-2026

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and...

Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone

Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone

2:02 23-03-2026

Protagonist Therapeutics (NASDAQ: PTGX) executives said March 18 that the U.S. Food and Drug Adminis...

Protagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's Why

Protagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's Why

13:01 20-03-2026

PTGX stock jumps as JNJ wins FDA nod for Icotyde in plaque psoriasis, unlocking milestone payments a...

Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?

Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?

10:06 20-03-2026

Protagonist Therapeutics (PTGX) saw its shares surge in the last session with trading volume being h...

Protagonist Therapeutics, Inc. (PTGX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Protagonist Therapeutics, Inc. (PTGX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

14:02 12-03-2026

Protagonist Therapeutics, Inc. (PTGX) Presents at Barclays 28th Annual Global Healthcare Conference ...

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in March 2026

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in March 2026

7:30 24-02-2026

NEWARK, CA / ACCESS Newswire / February 24, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or ...

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Given Consensus Recommendation of “Moderate Buy” by Analysts

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Given Consensus Recommendation of “Moderate Buy” by Analysts

1:48 19-02-2026

Protagonist Therapeutics, Inc. (NASDAQ: PTGX - Get Free Report) has been given a consensus rating of...

Protagonist Therapeutics Director Sells 20,000 Shares Amid Strong Stock Performance

Protagonist Therapeutics Director Sells 20,000 Shares Amid Strong Stock Performance

3:38 16-02-2026

A director for Protagonist Therapeutics sold 20,000 shares for a transaction value of approximately ...

Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes

Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes

0:25 01-02-2026

Arturo Molina sold 9,514 directly on Jan. 20, 2026, generating a transaction value of approximately ...

Protagonist Therapeutics (NASDAQ:PTGX) Insider Arturo Md Molina Sells 5,000 Shares

Protagonist Therapeutics (NASDAQ:PTGX) Insider Arturo Md Molina Sells 5,000 Shares

6:20 28-01-2026

Protagonist Therapeutics, Inc. (NASDAQ: PTGX - Get Free Report) insider Arturo Md Molina sold 5,000 ...

Protagonist Therapeutics (NASDAQ:PTGX) CEO Dinesh Ph Patel Sells 4,068 Shares

Protagonist Therapeutics (NASDAQ:PTGX) CEO Dinesh Ph Patel Sells 4,068 Shares

6:20 28-01-2026

Protagonist Therapeutics, Inc. (NASDAQ: PTGX - Get Free Report) CEO Dinesh Ph Patel sold 4,068 share...

Protagonist Therapeutics (NASDAQ:PTGX) Insider Arturo Md Molina Sells 13,151 Shares of Stock

Protagonist Therapeutics (NASDAQ:PTGX) Insider Arturo Md Molina Sells 13,151 Shares of Stock

5:35 28-01-2026

Protagonist Therapeutics, Inc. (NASDAQ: PTGX - Get Free Report) insider Arturo Md Molina sold 13,151...

Protagonist Therapeutics (NASDAQ:PTGX) CFO Asif Ali Sells 46,203 Shares of Stock

Protagonist Therapeutics (NASDAQ:PTGX) CFO Asif Ali Sells 46,203 Shares of Stock

5:35 28-01-2026

Protagonist Therapeutics, Inc. (NASDAQ: PTGX - Get Free Report) CFO Asif Ali sold 46,203 shares of t...

Protagonist Therapeutics (NASDAQ:PTGX) CEO Dinesh Ph Patel Sells 19,315 Shares

Protagonist Therapeutics (NASDAQ:PTGX) CEO Dinesh Ph Patel Sells 19,315 Shares

5:34 28-01-2026

Protagonist Therapeutics, Inc. (NASDAQ: PTGX - Get Free Report) CEO Dinesh Ph Patel sold 19,315 shar...

close

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE 2026

07-01-2026
NEWARK, CA / ACCESS NEWSWIRE / JANUARY 7, 2026 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR TH...
Více zde

TAKEDA AND PROTAGONIST ANNOUNCE SUBMISSION OF NEW DRUG APPLICATION (NDA) FOR RUSFERTIDE FOR TREATMENT OF POLYCYTHEMIA VERA (PV)

05-01-2026
OSAKA, JAPAN & CAMBRIDGE, MASS. & NEWARK, CALIF.--(BUSINESS WIRE)--TAKEDA (TSE:4502/NYSE:TAK) AND PR...
Více zde

PROTAGONIST AND TAKEDA PRESENT LONGER-TERM DATA AT ASH 2025 SHOWING RUSFERTIDE DELIVERS DURABLE RESPONSE AND HEMATOCRIT CONTROL IN POLYCYTHEMIA VERA

06-12-2025
NEWARK, CALIF. & OSAKA, JAPAN & CAMBRIDGE, MASS.--(BUSINESS WIRE)--PROTAGONIST THERAPEUTICS, INC. (...
Více zde

PROTAGONIST REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

06-11-2025
FOLLOWING THE NDA SUBMISSION FOR ICOTROKINRA TREATMENT OF ADULTS AND ADOLESCENTS WITH MODERATE TO SE...
Více zde

PROTAGONIST THERAPEUTICS ANNOUNCES ORAL AND POSTER PRESENTATIONS ON RUSFERTIDE AT THE 67TH ANNUAL ASH MEETING

03-11-2025
NEWARK, CALIFORNIA / ACCESS NEWSWIRE / NOVEMBER 3, 2025 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONI...
Více zde

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN MULTIPLE INVESTMENT BANK CONFERENCES IN SEPTEMBER 2025

26-08-2025
NEWARK, CALIFORNIA / ACCESS NEWSWIRE / AUGUST 26, 2025 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIS...
Více zde

PROTAGONIST REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

06-08-2025
NDA FOR ICOTROKINRA FOR THE TREATMENT OF ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER WITH MODER...
Více zde

PROTAGONIST THERAPEUTICS TO HOST CONFERENCE CALL TO ANNOUNCE AN ORAL OBESITY DEVELOPMENT CANDIDATE

26-06-2025
WEBCAST AND CONFERENCE CALL TO BE HELD ON MONDAY, JUNE 30TH AT 4:30 PM ET, DIAL IN INFORMATION BELOW...
Více zde

PROTAGONIST AND TAKEDA ANNOUNCE ASCO PLENARY PRESENTATION HIGHLIGHTING FULL 32-WEEK RESULTS FROM PHASE 3 VERIFY STUDY OF RUSFERTIDE, SHOWING REDUCTIONS IN PHLEBOTOMY, IMPROVED HEMATOCRIT CONTROL IN POLYCYTHEMIA VERA

01-06-2025
NEWARK, CALIF. & OSAKA, JAPAN & CAMBRIDGE, MASS.--(BUSINESS WIRE)--PROTAGONIST THERAPEUTICS, INC. (...
Více zde

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE 2025

21-05-2025
NEWARK, CA / ACCESS NEWSWIRE / MAY 21, 2025 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR THE "...
Více zde

PROTAGONIST REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

06-05-2025
POSITIVE TOP LINE RESULTS FROM RUSFERTIDE PHASE 3 VERIFY TRIAL IN POLYCYTHEMIA VERA (PV) ANNOUNCED; ...
Více zde

PROTAGONIST THERAPEUTICS ANNOUNCES PLENARY PRESENTATION ON VERIFY PHASE 3 STUDY WITH RUSFERTIDE AT ASCO 2025

23-04-2025
NEWARK, CA / ACCESS NEWSWIRE / APRIL 23, 2025 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR THE...
Více zde

PROTAGONIST THERAPEUTICS REPORTS GRANTING OF INDUCEMENT AWARD

16-04-2025
NEWARK, CA / ACCESS NEWSWIRE / APRIL 16, 2025 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR THE...
Více zde

PROTAGONIST THERAPEUTICS NAMED TO FAST COMPANY'S ANNUAL LIST OF THE WORLD'S MOST INNOVATIVE COMPANIES OF 2025

18-03-2025
PAST WINNERS INCLUDE WAYMO, NVIDIA, DUOLINGO, AND NOVO NORDISK, AMONG OTHERS NEWARK, CA / ACCESS NEW...
Více zde

PROTAGONIST AND TAKEDA ANNOUNCE POSITIVE TOPLINE RESULTS FROM PHASE 3 VERIFY STUDY OF RUSFERTIDE IN PATIENTS WITH POLYCYTHEMIA VERA

03-03-2025
NEWARK, CALIF. & OSAKA, JAPAN & CAMBRIDGE, MASS.--(BUSINESS WIRE)--PROTAGONIST THERAPEUTICS, INC. (...
Více zde

PROTAGONIST REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

21-02-2025
$165.0 MILLION ICOTROKINRA (FORMERLY JNJ-2113) MILESTONE EARNED IN Q4 2024, RECEIVED IN JANUARY 2025...
Více zde

PROTAGONIST THERAPEUTICS REPORTS GRANTING OF INDUCEMENT AWARDS

06-01-2025
NEWARK, CALIFORNIA / ACCESSWIRE / JANUARY 6, 2025 / PROTAGONIST THERAPEUTICS, INC. (NASDAQ:PTGX) TOD...
Více zde

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE 2025

19-12-2024
NEWARK, CA / ACCESSWIRE / DECEMBER 19, 2024 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR THE "...
Více zde

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN THE 7TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE 2024

22-11-2024
NEWARK, CA / ACCESSWIRE / NOVEMBER 22, 2024 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR THE "...
Více zde

PROTAGONIST THERAPEUTICS TO HOST CONFERENCE CALL TO ANNOUNCE AN ORAL PEPTIDE IL-17 ANTAGONIST DEVELOPMENT CANDIDATE

19-11-2024
WEBCAST AND CONFERENCE CALL TO BE HELD BE ON THURSDAY, NOVEMBER 21ST AT 4:30 PM ET, DIAL IN INFORMAT...
Více zde

PROTAGONIST REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

07-11-2024
TOP LINE RESULTS FOR JNJ-2113 PHASE 3 ICONIC-LEAD AND PHASE 3 ICONIC-TOTAL CLINICAL TRIALS IN PATIEN...
Více zde

PROTAGONIST THERAPEUTICS ANNOUNCES POSTER PRESENTATION ON FINAL REVIVE PHASE 2 STUDY DATA WITH RUSFERTIDE AT THE 66TH ANNUAL ASH MEETING

05-11-2024
NEWARK, CA / ACCESSWIRE / NOVEMBER 5, 2024 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR THE "C...
Více zde

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN THE H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE 2024

03-09-2024
NEWARK, CA / ACCESSWIRE / SEPTEMBER 3, 2024 / PROTAGONIST THERAPEUTICS, INC. (NASDAQ:PTGX) ("PROTAGO...
Více zde

PROTAGONIST REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

06-08-2024
JNJ-2113 PHASE 3 ICONIC-LEAD AND PHASE 3 ICONIC-TOTAL CLINICAL TRIALS IN MODERATE-TO-SEVERE PLAQUE P...
Více zde

PROTAGONIST ANNOUNCES APPOINTMENT OF NEWMAN YEILDING, M.D. AS CHIEF SCIENTIFIC ADVISOR

31-07-2024
DR. YEILDING JOINS PROTAGONIST FROM JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON, WHERE HE ...
Více zde

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN THE BTIG VIRTUAL BIOTECHNOLOGY CONFERENCE 2024

22-07-2024
NEWARK, CA / ACCESSWIRE / JULY 22, 2024 / PROTAGONIST THERAPEUTICS, INC. (NASDAQ:PTGX) ("PROTAGONIST...
Více zde

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE 2024

31-05-2024
NEWARK, CA / ACCESSWIRE / MAY 31, 2024 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR THE "COMPA...
Více zde

PROTAGONIST THERAPEUTICS ANNOUNCES ORAL PRESENTATION ON LONG-TERM FOLLOW-UP OF RUSFERTIDE PHASE 2 REVIVE STUDY OPEN LABEL EXTENSION AT THE EUROPEAN HEMATOLOGY ASSOCIATION 2024 CONGRESS

14-05-2024
NEWARK, CA / ACCESSWIRE / MAY 14, 2024 / PROTAGONIST THERAPEUTICS, INC. (NASDAQ:PTGX) ("PROTAGONIST"...
Více zde

PROTAGONIST THERAPEUTICS TO PARTICIPATE IN THE CITIZENS JMP LIFE SCIENCES CONFERENCE AND THE CAPITAL ONE 1ST ANNUAL BIOTECH/BIOPHARMA DISRUPTORS EVENT

07-05-2024
NEWARK, CA / ACCESSWIRE / MAY 7, 2024 / PROTAGONIST THERAPEUTICS, INC. ("PROTAGONIST" OR THE "COMPAN...
Více zde

PROTAGONIST REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

07-05-2024
ENTERED INTO A WORLDWIDE LICENSE AND COLLABORATION AGREEMENT FOR RUSFERTIDE WITH TAKEDA; CASH RUNWAY...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-08-06 01:00:008-KStáhnout
2025-08-06 01:00:0010-QStáhnout
2025-08-06 00:00:008-KStáhnout
2025-08-06 00:00:0010-QStáhnout
2025-06-26 01:00:008-KStáhnout
2025-06-26 00:00:008-KStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 01:00:0010-QStáhnout
2025-05-06 00:00:008-KStáhnout
2025-05-06 00:00:0010-QStáhnout
2025-03-20 00:00:008-KStáhnout
2025-03-19 23:00:008-KStáhnout
2025-03-10 00:00:008-KStáhnout
2025-03-09 23:00:008-KStáhnout
2025-03-03 00:00:008-KStáhnout
2025-03-02 23:00:008-KStáhnout
2025-02-21 00:00:008-KStáhnout
2025-02-21 00:00:0010-KStáhnout
2025-02-20 23:00:008-KStáhnout
2025-02-20 23:00:0010-KStáhnout
2025-01-06 00:00:008-KStáhnout
2025-01-05 23:00:008-KStáhnout
2024-11-18 00:00:008-KStáhnout
2024-11-17 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-09-20 01:00:008-KStáhnout
2024-09-20 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-06-26 01:00:008-KStáhnout
2024-06-26 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2024-01-31 00:00:008-KStáhnout
2024-01-30 23:00:008-KStáhnout
2024-01-16 00:00:008-KStáhnout
2024-01-15 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-10-30 00:00:008-KStáhnout
2023-10-29 23:00:008-KStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 01:00:0010-QStáhnout
2023-08-03 00:00:008-KStáhnout
2023-08-03 00:00:0010-QStáhnout
2023-07-05 01:00:008-KStáhnout
2023-07-05 00:00:008-KStáhnout
2023-07-03 01:00:008-KStáhnout
2023-07-03 00:00:008-KStáhnout
2023-05-30 01:00:008-KStáhnout
2023-05-30 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-04-10 01:00:008-KStáhnout
2023-04-10 00:00:008-KStáhnout
2023-03-15 00:00:008-KStáhnout
2023-03-15 00:00:0010-KStáhnout
2023-03-14 23:00:008-KStáhnout
2023-03-14 23:00:0010-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-01-06 00:00:008-KStáhnout
2023-01-05 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-06-02 01:00:008-KStáhnout
2022-06-02 00:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 00:00:008-KStáhnout
2022-04-26 01:00:008-KStáhnout
2022-04-26 00:00:008-KStáhnout
2022-04-13 01:00:008-KStáhnout
2022-04-13 00:00:008-KStáhnout
2022-03-31 01:00:008-KStáhnout
2022-03-31 00:00:008-KStáhnout
2022-03-23 00:00:008-KStáhnout
2022-03-22 23:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-21 23:00:008-KStáhnout
2021-11-03 00:00:008-KStáhnout
2021-11-03 00:00:0010-QStáhnout
2021-11-02 23:00:008-KStáhnout
2021-11-02 23:00:0010-QStáhnout
2021-09-17 01:00:008-KStáhnout
2021-09-17 00:00:008-KStáhnout
2021-08-10 01:00:008-KStáhnout
2021-08-10 00:00:008-KStáhnout
2021-08-04 01:00:008-KStáhnout
2021-08-04 01:00:0010-QStáhnout
2021-08-04 00:00:008-KStáhnout
2021-08-04 00:00:0010-QStáhnout
2021-07-28 01:00:008-KStáhnout
2021-07-28 00:00:008-KStáhnout
2021-06-17 01:00:008-KStáhnout
2021-06-17 00:00:008-KStáhnout
2021-06-14 01:00:008-KStáhnout
2021-06-14 00:00:008-KStáhnout
2021-05-28 01:00:008-KStáhnout
2021-05-28 00:00:008-KStáhnout
2021-05-04 01:00:008-KStáhnout
2021-05-04 01:00:0010-QStáhnout
2021-05-04 00:00:008-KStáhnout
2021-05-04 00:00:0010-QStáhnout
2021-03-10 00:00:008-KStáhnout
2021-03-10 00:00:0010-KStáhnout
2021-03-09 23:00:008-KStáhnout
2021-03-09 23:00:0010-KStáhnout
2020-12-11 00:00:008-KStáhnout
2020-12-10 23:00:008-KStáhnout
2020-11-04 00:00:008-KStáhnout
2020-11-04 00:00:0010-QStáhnout
2020-11-03 23:00:008-KStáhnout
2020-11-03 23:00:0010-QStáhnout
2020-09-11 01:00:008-KStáhnout
2020-09-11 00:00:008-KStáhnout
2020-08-13 01:00:008-KStáhnout
2020-08-13 00:00:008-KStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-05-29 01:00:008-KStáhnout
2020-05-29 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-03-18 00:00:008-KStáhnout
2020-03-17 23:00:008-KStáhnout
2020-03-10 00:00:008-KStáhnout
2020-03-10 00:00:0010-KStáhnout
2020-03-09 23:00:008-KStáhnout
2020-03-09 23:00:0010-KStáhnout
2020-02-24 00:00:008-KStáhnout
2020-02-23 23:00:008-KStáhnout
2019-12-03 00:00:008-KStáhnout
2019-12-02 23:00:008-KStáhnout
2019-11-27 00:00:008-KStáhnout
2019-11-26 23:00:008-KStáhnout
2019-11-06 00:00:008-KStáhnout
2019-11-06 00:00:0010-QStáhnout
2019-11-05 23:00:008-KStáhnout
2019-11-05 23:00:0010-QStáhnout
2019-10-31 00:00:008-KStáhnout
2019-10-30 23:00:008-KStáhnout
2019-08-07 01:00:008-KStáhnout
2019-08-07 01:00:0010-QStáhnout
2019-08-07 00:00:008-KStáhnout
2019-08-07 00:00:0010-QStáhnout
2019-06-13 01:00:008-KStáhnout
2019-06-13 00:00:008-KStáhnout
2019-05-29 01:00:008-KStáhnout
2019-05-29 00:00:008-KStáhnout
2019-05-13 01:00:008-KStáhnout
2019-05-13 00:00:008-KStáhnout
2019-05-08 01:00:008-KStáhnout
2019-05-08 01:00:0010-QStáhnout
2019-05-08 00:00:008-KStáhnout
2019-05-08 00:00:0010-QStáhnout
2019-03-25 00:00:008-KStáhnout
2019-03-24 23:00:008-KStáhnout
2019-03-12 00:00:008-KStáhnout
2019-03-12 00:00:0010-KStáhnout
2019-03-11 23:00:008-KStáhnout
2019-03-11 23:00:0010-KStáhnout
2018-12-31 00:00:008-KStáhnout
2018-12-30 23:00:008-KStáhnout
2018-11-27 00:00:008-KStáhnout
2018-11-26 23:00:008-KStáhnout
2018-11-06 00:00:008-KStáhnout
2018-11-06 00:00:0010-QStáhnout
2018-11-05 23:00:008-KStáhnout
2018-11-05 23:00:0010-QStáhnout
2018-10-22 01:00:008-KStáhnout
2018-10-22 00:00:008-KStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 01:00:0010-QStáhnout
2018-08-07 00:00:008-KStáhnout
2018-08-07 00:00:0010-QStáhnout
2018-08-06 01:00:008-KStáhnout
2018-08-06 00:00:008-KStáhnout
2018-05-31 01:00:008-KStáhnout
2018-05-31 00:00:008-KStáhnout
2018-05-16 01:00:008-KStáhnout
2018-05-16 00:00:008-KStáhnout
2018-05-09 01:00:008-KStáhnout
2018-05-09 01:00:0010-QStáhnout
2018-05-09 00:00:008-KStáhnout
2018-05-09 00:00:0010-QStáhnout
2018-03-26 01:00:008-KStáhnout
2018-03-26 00:00:008-KStáhnout
2018-03-07 00:00:008-KStáhnout
2018-03-07 00:00:0010-KStáhnout
2018-03-06 23:00:008-KStáhnout
2018-03-06 23:00:0010-KStáhnout
2018-02-27 00:00:008-KStáhnout
2018-02-26 23:00:008-KStáhnout
2018-01-08 00:00:008-KStáhnout
2018-01-07 23:00:008-KStáhnout
2017-12-14 00:00:008-KStáhnout
2017-12-13 23:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-11-06 00:00:008-KStáhnout
2017-11-05 23:00:008-KStáhnout
2017-10-13 01:00:008-KStáhnout
2017-10-13 00:00:008-KStáhnout
2017-08-08 01:00:008-KStáhnout
2017-08-08 01:00:0010-QStáhnout
2017-08-08 00:00:008-KStáhnout
2017-08-08 00:00:0010-QStáhnout
2017-06-08 01:00:008-KStáhnout
2017-06-08 00:00:008-KStáhnout
2017-05-30 01:00:008-KStáhnout
2017-05-30 00:00:008-KStáhnout
2017-05-25 01:00:008-KStáhnout
2017-05-25 00:00:008-KStáhnout
2017-05-23 01:00:008-KStáhnout
2017-05-23 00:00:008-KStáhnout
2017-05-10 01:00:008-KStáhnout
2017-05-10 01:00:0010-QStáhnout
2017-05-10 00:00:008-KStáhnout
2017-05-10 00:00:0010-QStáhnout
2017-03-07 00:00:008-KStáhnout
2017-03-07 00:00:0010-KStáhnout
2017-03-06 23:00:008-KStáhnout
2017-03-06 23:00:0010-KStáhnout
2017-02-09 00:00:008-KStáhnout
2017-02-08 23:00:008-KStáhnout
2016-11-14 00:00:008-KStáhnout
2016-11-14 00:00:0010-QStáhnout
2016-11-13 23:00:008-KStáhnout
2016-11-13 23:00:0010-QStáhnout
2016-09-15 01:00:0010-QStáhnout
2016-09-15 00:00:0010-QStáhnout
2016-08-16 01:00:008-KStáhnout
2016-08-16 00:00:008-KStáhnout
preloader